
LA JOLLA, Calif., March 10 (UPI) -- The drug Benlysta, or belimumab, has been approved by the U.S. Food and Drug Administration to treat the most common type of lupus.
Dr. Richard A. Lerner, president of Scripps Research, said Benlysta, developed by GlaxoSmithKline and Human Genome Sciences, is the first new drug treatment for lupus in 50 years.
"I am deeply gratified that our scientific findings have proven so valuable to drug discovery," Lerner said in a statement. "This development underlines the importance of basic academic science in laying important groundwork for life-saving medical advances."
The drug is approved for systemic lupus erythematosus -- a chronic, life-threatening inflammatory disease affecting the joints, skin, kidneys, blood, heart and lungs.
Benlysta targets a specific protein -- B-lymphocyte stimulator -- involved in stimulating the "autoantibodies" causing lupus and certain other autoimmune disorders, Lerner said.
|
|
|
|
|
|
| Additional Health News Stories | |
MIAMI, May 27 (UPI) --
Tropical Storm Beryl was expected to make landfall Sunday night on the Southeast Coast of the United States, U.S. forecasters said.
|
WINSTON-SALEM, N.C., May 27 (UPI) --
Bluegrass legend Arthel "Doc" Watson was in critical condition following colon surgery at a hospital in Winston-Salem, N.C., his representative said.
|
ANCHORAGE, Alaska, May 27 (UPI) --
A black bear didn't go over a river but went to the woods after scampering through residential and industrial areas of Anchorage, Alaska, police said.
|
To avoid a meltdown in 2006, Ford Motor Co. mortgaged the farm putting up its assets – including its Blue Oval logo, and F-150 pickup and iconic Mustang trademarks – to secure $23.5 billion in credit.
|
| Stories | Photos | People | Comments |
View Caption